🎉 Big milestone for the Mediterranean Journal of Rheumatology!.We are proud to announce our first-ever Impact Factor: 1.4 (JCR 2024) 📊✨.This achievement reflects the dedication of our authors, reviewers, and editorial team — thank you for being part of this journey!

Check out the latest issue of MJR!!.🔹 Infrared Thermography in RMDs.🔹 Cortisol & RA outcomes.🔹 Anti-TIF1γ myositis.🔹 What do rheumatologists know about reproductive health?.and much more!!

The MJR June 2025 Issue is online! -

Exciting news for the MJR: The JCR 2024 Impact Factors are out! -

🆕 Physical modalities for #fibromyalgia pain relief.💡 Review highlights:.🔹 Exercise.🔹 Hydrotherapy.🔹 TENS.🔹 Low-level laser & magnetic therapy.📌 Safe non-pharma options for FM care.👉

📌 What happens when #Fibromyalgia meets #pregnancy?.✅ Symptom worsening (pain, anxiety, depression).✅ Higher rates of gestational diabetes.✅ Mixed findings on neonatal outcomes (prematurity, low Apgar).Read more .👉

Starting #apremilast in #PsA?.This new multicentre real-world study shows that baseline musculoskeletal #ultrasound helps select better responders, improving drug retention. 👉

🧡 World AS Day – 3 May 2025 #worldasday2025.Even simple tasks, like tying shoelaces, can be a challenge for those living with #axSpA.We join the #LaceUpForAxSpA campaign and invite you to explore our special issue dedicated to axSpA 👉

The MJR March 2025 Issue is online! -

🔥New Issue Alert!.The March 2025 issue is out now! In this issue:.✅Pregnancy & Fibromyalgia.✅HLA-DRB1* & Autoimmune Skin Disorders.✅ Physical modalities for Pain therapies in Fibromyalgia.✅AI in Autoimmunity.✅Diet & Inflammation.& more

Only 48% of Greek patients with rheumatic diseases know what biosimilars are, and 81% want more info. 📊 Survey of 309 patients reveals major knowledge gaps and concerns about safety & efficacy. 🧠 Urgent need for patient education!.

Oral Hyaluronic Acid in #Osteoarthritis & Low Back Pain.🔹 11 studies, 597 patients.🔹 80% showed improvement in pain & function.🔹 Safe, well-tolerated alternative to injections.👉

iTNFα vs. Newer Therapies in #SpA.✅ iTNFα inhibitors work across all SpA types.✅ IL-17i help #axSpA & #PsA but may worsen #IBD.✅ IL-12/IL-23i aid PsA & IBD but not axSpA.✅ JAKi show promise, but caution in elderly.👉

A new study on Anti-MDA5 Antibody-Associated RP-ILD .⚠️ High mortality risk—early intervention is key.✅ Early detection improves outcomes.📊 High ferritin & LDH predict poor prognosis.💊 Mixed results with combination therapy.👉

Atlantoaxial subluxation in #AxSpA.👉Rare but serious—watch for:.🔹 Persistent neck pain & stiffness.🔹 Limb weakness or numbness.🔹 Limited cervical motion.✅ MRI/CT > X-ray for diagnosis.✅ Surgery (C1-C2 fusion) often needed

📢MJR has been accepted for indexing by Emerging Sources Citation Index (Clarivate)👉The first Journal Impact Factor will be available next year. Congratulations to all contributors to this great achievement! 🎉

🔥New review on the Paradox of #Osteoporosis in #SpA👉✅ Prevalence and risk factors in #AxSpA & #PsA.✅ Impact of inflammatory cytokines (TNF, IL-17A) on bone loss.✅ Managing dual processes: new bone formation vs. bone loss

🔥 Special Issue of @MJR_journal on #Spondyloarthritis #SpA is here! .👉 Featuring:.✅Challenging cases in #PsA & #AxSpA.✅TNFα inhibitors vs. novel therapies.✅The paradox of #osteoporosis in SpA.✅Highlights from #EULAR & #ACR congresses.Stay updated!!

MJR: Special Issue on Spondylarthritides -

🔥A new review on D2M #axSpA.👉🩺The @Official_ASAS definition.📊20–28% prevalence in clinical settings.💡Key contributors: persistent inflammation, #comorbidity #fibromyalgia #depression & treatment resistance.✅Proposed strategies for tailored management